Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/20/2003US20030215937 Conductive microplate
11/20/2003US20030215933 Comprises genetically engineered cell for propagating variation in ribozymes or enzymes using repeat induced point mutation (RIP)
11/20/2003US20030215930 Genes involved in cyclododecanone degradation pathway
11/20/2003US20030215927 UDP-glucosyltransferases
11/20/2003US20030215926 Preparing RNA/DNA hybrid sequences; genetic engineering; phenotype analysis
11/20/2003US20030215925 Topoisomerase-based reagents and methods for molecular cloning
11/20/2003US20030215924 Ribocloning: recombinant DNA construction using primers with ribo bases
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215920 Comprises nucleotide sequences coding pichia oxidoreductase for use as selectable marker in genetic engineering
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215916 Comprises nucleotide sequences coding membrane protein for diagnosisng and treating tumor, nervous sytem, reproductive, pain and sexual disorders
11/20/2003US20030215915 Cytochrome P450 expression in enterobacteria
11/20/2003US20030215914 Invention provides versatile context for presenting desired affinity regions; provides structural context design based on a common structural element (core structure) that has been identified herein to occur in numerous binding proteins
11/20/2003US20030215913 Comprises nucleotide sequences coding transfroming growth factor (LP266) for treating nervous system, cell proliferative, bone, fibrotic and cardiovascular disorders; wound healing/antiproliferative agents; tissue repair
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215907 Comprise nucleotide sequences coding enzymatic polypeptide for use as modification and selection tools in genetic engineering
11/20/2003US20030215906 Recombinant bacillus proteases and uses thereof
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215888 Genetically engineered myoblast for identifying antiproliferative agents; antiapoptosis; drug screening
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215883 Preparing and screening gene libraries for bioactive proteins with altered heat resistance
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215864 Improved DNA hybridization/conjugation
11/20/2003US20030215861 Methods of treating a BRCA associated disorder
11/20/2003US20030215859 Biocatalytic polypeptides having improved stereospecificity for production of hydroxycarboxylic acids and aryl/alkyl-hydroxy compounds; glycosyltransferases; improved solvent resistance of microorganisms used; drug screening
11/20/2003US20030215858 Enhanced gene expression system
11/20/2003US20030215854 Identifying transcription factors for use in modulation of gene expression; high-throughput assay
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215846 Methods of constructing and screening diverse expression libraries
11/20/2003US20030215845 Selective extraction of DNA from groups of cells
11/20/2003US20030215841 Using fluorescent microscopy to concurrently monitor gene expression/transcription from a multiplicity of genes; diagnosing cancer and viral diseases
11/20/2003US20030215840 Identifying compounds capable of treating atherosclerosis, reperfusion injury, hypertension, restenosis, arterial inflammation, heart failure, thrombosis and endothelial cell disorders
11/20/2003US20030215839 Methods and means for identification of gene features
11/20/2003US20030215834 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program
11/20/2003US20030215832 Method for processing blood samples in order to produce DNA complex patterns for diagnostic applications
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215830 Using polymerase chain reaction to identify and measure messenger RNA present in sample
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215828 Gene markers for lung cancer
11/20/2003US20030215826 Labeled oligonucleotides for use as diagnostic tools in nucleic acid replication
11/20/2003US20030215824 Identifying modulators of apoptosis such as XIAP associated factor 1 (XAF-1); for treating and diagnosing cell proliferative disorders; drug screening; antiproliferative agents
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215819 Compositions and methods for inferring a response to statin
11/20/2003US20030215818 Method for nucleic acid extraction and nucleic acid purification
11/20/2003US20030215816 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups
11/20/2003US20030215812 Gene encoding beta-mannanase, enzyme preparation and uses thereof
11/20/2003US20030215805 Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancer
11/20/2003US20030215803 Isolated polynucleotide which hybridizes to given sequence; use in diagnosing cancer and for inhibiting tumor growth
11/20/2003US20030215802 Simultaneous detection,identification and differentiation of eubacterial taxa using a hybridization assay
11/20/2003US20030215800 Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation
11/20/2003US20030215799 In vitro transposition in conjunction with an chromosomal integration vector; transformation and screening for specific phenotype
11/20/2003US20030215798 Inserting bioactive substrates into samples from a prokaryotic expression library; fluorescence analyzers; determinig DNA sequence of positive biocatalysts
11/20/2003US20030215796 Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
11/20/2003US20030215795 Highly infectious rubella virus DNA constructs and methods of production
11/20/2003US20030215794 Filovirus vectors and noninfectious Filovirus-based particles
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215489 Chemosensitizing with liposomes containing oligonucleotides
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215463 Replication defective herpes virus vector has a deletion of at least a fragment of a UL29 gene that is replaced with a heterologous sequence encoding an antigen from a specific infectious disease agent
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215452 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/20/2003US20030215451 In treatment (including prevention) or identification of a human subject at risk of tissue damage, preferably liver or heart tissue damage
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003US20030215446 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215424 Method of modulating angiogenesis
11/20/2003US20030215423 Drug delivery a genetic engineered vector, encoding protein hormone in vivo; a helper dependent adenoviral vector
11/20/2003US20030215422 Aav4 vector and uses thereof
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003US20030215364 Especially useful with sample tubes having penetrable caps.
11/20/2003CA2823041A1 Fgf variants and methods for use thereof
11/20/2003CA2805053A1 Pyrophosphorolysis activated polymerization (pap)
11/20/2003CA2523888A1 Transgenic rat and the use thereof in the animal model for human huntingdon's disease and nuclear constructs, vectors and cells for the production thereof
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2485655A1 Recombinant fowlpox virus
11/20/2003CA2485489A1 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol
11/20/2003CA2485452A1 Process for generating sequence-specific proteases by directed evolution and use thereof
11/20/2003CA2485439A1 Anth1 chimeric antagonist
11/20/2003CA2485400A1 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2485363A1 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003CA2485256A1 Pathogen vaccines and methods for using the same
11/20/2003CA2485137A1 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
11/20/2003CA2485119A1 Promoters with modified transcription efficiency
11/20/2003CA2484897A1 Soluble st2 as a cardiovascular disease marker and therapeutic target
11/20/2003CA2484704A1 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003CA2484701A1 Control of es cell self renewal and lineage specification, and medium therefor
11/20/2003CA2484669A1 Brachyspira hyodysenteriae vaccine
1 ... 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 ... 4023